Test Id : FD10S
Drugs of Abuse Screen, Serum
Reflex Tests
Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.
| Test Id | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| FAMCS | Amphetamines Confirmation, S | No | No |
| FBCS | Benzodiazepines Confirmation, S | No | No |
| FCANS | Cannabinoids Confirmation, S | No | No |
| FCMC | Cocaine and Metabolites Confirm, S | No | No |
| FMMCS | Methadone and Metabolite Confirm, S | No | No |
| FF10S | Fentanyl/Acetyl Fentanyl Confirm, S | No | No |
| FOFU | Opiates-Free Unconjugated Conf, S | No | No |
| FPCCS | Phencyclidine Confirmation, S | No | No |
| FBCFS | Barbiturates Confirmation, S | No | No |
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
If appropriate, confirmation testing will be performed at an additional charge.
Method Name
A short description of the method used to perform the test
Enzyme-Linked Immunosorbent Assay (ELISA)
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
Aliases
Lists additional common names for a test, as an aid in searching
Opiates
Cocaine/Metabolites
Benzodiazepines
Cannabinoids
Amphetamines
Barbiturates
Methadone/Metabolite
Phencyclidine
Methamphetamine/MDMA
Oxycodone/Oxymorphone
Amfetamine
Cannabis
Coke
Desoxyn
Dextroamphetamine
Ecstasy
Heroin
Levoamphetamine
Marijuana
Meth
Molly
THC
Tranquilizer
Crack
Fentanyl/Acetyl Fentanyl
Adderall
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
If appropriate, confirmation testing will be performed at an additional charge.
Specimen Type
Describes the specimen type validated for testing
Serum Red
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
***Must submit one specimen per order. Specimens cannot be shared between multiple orders.***
Specimen Type: Serum
Collection Container/Tube: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 4 mL
Collection Instructions:
1. Draw blood in a plain, red-top tube(s), serum gel tube is not acceptable.
2. Centrifuge and send 4 mL of serum refrigerated in plastic, preservative-free vial.
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.
1.75 mL
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
| Other | Polymer gel separation tube (SST or PST). |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum Red | Refrigerated (preferred) | 7 days | |
| Frozen | 14 days |
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
If appropriate, confirmation testing will be performed at an additional charge.
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Reporting limit determined each analysis.
| Test | Result | Units |
| Opiates | None Detected | ng/mL |
| Cocaine/Metabolites | None Detected | ng/mL |
| Benzodiazepines | None Detected | ng/mL |
| Cannabinoids | None Detected | ng/mL |
| Amphetamines | None Detected | ng/mL |
| Barbiturates | None Detected | mcg/mL |
| Fentanyl/Acetyl Fentanyl | None Detected | ng/mL |
| Methadone/Metabolite | None Detected | ng/mL |
| Phencyclidine | None Detected | ng/mL |
| Methamphetamine/MDMA | None Detected | ng/mL |
| Oxycodone/Oxymorphone | None Detected | ng/mL |
PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.
Monday through Sunday
Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
Performing Laboratory Location
Indicates the location of the laboratory that performs the test
Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their account representative. For assistance, contact Customer Service.
Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the U.S. Food and Drug Administration.
CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
CPT codes are provided by the performing laboratory.
80307
LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.
| Test Id | Test Order Name | Order LOINC Value |
|---|---|---|
| FD10S | Drugs of Abuse Screen, S | Not Provided |
| Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
|---|---|---|
| Z5245 | Opiates | 8219-8 |
| Z5246 | Cocaine/Metabolites | 73823-7 |
| Z5247 | Benzodiazepines | 46976-7 |
| Z5248 | Cannabinoids | 8172-9 |
| Z5249 | Amphetamines | 8149-7 |
| Z5250 | Barbiturates | 20421-4 |
| Z5251 | Methadone/Metabolite | 91033-1 |
| Z5252 | Phencyclidine | 8236-2 |
| Z5253 | Methamphetamine/MDMA | 91034-9 |
| Z5254 | Oxycodone/Oxymorphone | 77732-6 |
| Z6248 | Fentanyl/Acetyl Fentanyl | 29356-3 |